MCC
IHE icon

Money Concepts Capital’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Money Concepts Capital’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-105
Closed -$6.51K – 1655
2022
Q4 		$6.51K Buy
+105
New +$6.32K ﹤0.01% 2223
2022
Q2 		– Sell
-132
Closed -$9K – 2017
2022
Q1 		$9K Buy
+132
New +$8.37K ﹤0.01% 1983

Other funds holding IHE

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
RIG
RiverFront Investment Group Richmond, Virginia $7.56B AUM 23.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return

Money Concepts Capital's IHE Position: Q1 2023 in Review

Money Concepts Capital sold out of iShares US Pharmaceuticals ETF (IHE) in Q1 2023, closing a stake of 105 shares — an estimated $6.51K sold.

Money Concepts Capital first reported a position in IHE in Q1 2022 and held it in 2 quarters. The position peaked at $9K in Q1 2022. 127 funds tracked by Wall St. Rank hold IHE as of Q1 2023.

  • Money Concepts Capital reported no remaining iShares US Pharmaceuticals ETF position as of Q1 2023 after selling out during the quarter.
  • Money Concepts Capital sold 105 iShares US Pharmaceuticals ETF shares in Q1 2023, an estimated $6.51K.
  • Money Concepts Capital first reported a position in iShares US Pharmaceuticals ETF in Q1 2022 and held it in 2 quarters.
  • Money Concepts Capital's iShares US Pharmaceuticals ETF position peaked at $9K in Q1 2022.
  • 127 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2023.

Based on Money Concepts Capital's 13F filing for Q1 2023, filed 1 May 2023.